Conference abstract · 26 Sep 2016
Conference abstractPublished 2018
Tracking glioma progression by genetic barcoding
Università degli studi di Genova, Italy IRCCS AOU San Martino, Italy
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
During tumor progression, transformed cells accumulate mutations and gain malignancy. By now, it is unclear how easily this process can be undertaken and if it can be considered the main bottleneck in tumorigenesis. To measure the probability of glioma progression, we used a well-characterized murine model of gliomagenesis, induced by overexpressing PDGF-B in embryonic Neural Progenitor Cells (NPC), mimicking a possible first hit of tumorigenesis. In order to univocally tag each PDGF-transduced cell, we added a degenerated barcode sequence to the PDGF-B transducing vector and we produced high complexity libraries of barcoded retroviruses that had been injected in mouse embryos. After the development of gliomas, tumor masses were analyzed by NGS and compared to embryonic brains few days post infection. By using in-house developed software, we successfully retrieved barcodes from tumor masses and reconstructed the clonal composition of several independent tumors in different progression stages. Our data shows that even though low grade, partially progressed tumor masses are clonally heterogeneous and composed by about one thousand independent clones each, they are the result of a strong selection because the number of oncogene-transduced cells is more than 10 times higher. Still, high grade and fully progressed gliomas are characterized by a very low clonal complexity and often are composed by a single clone, suggesting another great bottleneck in glioma progression divides these two stages. More strikingly, fully progressed tumors derived from in vivo transplant the same pool of thousands different transduced NPCs are composed by the same clones, suggesting that a predetermined cell state is required to gain malignancy.
Subjects
Oncology & CancerAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Similar by topic
Opinion · 21 Dec 2022
Tracking the Progression of Cancer over the Duration of the Disease
Conference abstract · 9 May 2016
Tumor tracking and evolution analysis of hepatocellular carcinoma progression by ultra-deep sequencing of the entire mitochondrial genome
Conference abstract · 10 Aug 2015
Tracking cancer progression through monitoring the dynamic serum phospho-proteome
Opinion · 30 Jan 2023
Remedial Approaches of Glioma Genetics and Biology
More from this journal
The newest in Journal of Clinical & Experimental Oncology.
Review article · 3 Jul 2025
Efficacy of interventions for newly diagnosed multiple myeloma: An umbrella review
Research article · 10 Apr 2025
Multitargets and Interactions of Wortmannin with MSC-Mitogenic Proteins Validate the Enhanced Antiproliferative Effect of MSCSecretome on Breast Cancer Michigan Cancer Foundation-7 Cells
Mini review · 24 Jan 2025
Fractal Analysis in Medical Images
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Clinical & Experimental Oncology
- SubjectOncology & Cancer
- BylineArticles whose byline prints “Ceresa Davide”
- BylineArticles whose byline prints “Alessandrini Francesco”
- BylineArticles whose byline prints “Appolloni Irene”
- BylineArticles whose byline prints “Malatesta Paolo”

